The Latest Analyst Ratings For Ovid Therapeutics
The Latest Analyst Ratings For Ovid Therapeutics
Ovid Therapeutics的最新分析師評級
Ratings for Ovid Therapeutics (NASDAQ:OVID) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去三個月中，10位分析師提供了Ovid Therapeutics（納斯達克股票代碼：OVID）的評級，顯示了看漲和看跌的觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts have recently evaluated Ovid Therapeutics and provided 12-month price targets. The average target is $4.87, accompanied by a high estimate of $9.00 and a low estimate of $1.20. This current average represents a 24.38% decrease from the previous average price target of $6.44.
分析師最近對Ovid Therapeutics進行了評估，並提供了12個月的目標股價。平均目標爲4.87美元，最高估計值爲9.00美元，低估值爲1.20美元。目前的平均價格比之前的平均目標價6.44美元下降了24.38％。
Exploring Analyst Ratings: An In-Depth Overview
探索分析師評級：深入概述
The perception of Ovid Therapeutics by financial experts is...
通過分析師最近的行...
登入免費觀看全文
登入/註冊